SESSION Seq #28: Bisphosphonates & Osteonecrosis of the Jaw (ONJ)

Seq #28

Thursday, April 3, 2008

9:45 AM-11:15 AM
Hilton Anatole Hotel Monet Ballroom, Symposium - Group/Division Sponsored

Bisphosphonates & Osteonecrosis of the Jaw (ONJ)

Sponsored by: Craniofacial Biology, Implantology Research

Description: Osteonecrosis of the jaws (ONJ) is commonly associated with bisphosphonate (BP) therapy in cancer patients. However, no casual link has been established. In addition, patients being treated for osteoporosis with BP have also developed ONJ. There is no animal model for this disease and there is limited information on the pathogenesis of ONJ. The purpose of this symposium is invite speaker to address what is the scientific evidence from humans and animal models on the pathogenesis of ONJ. The speakers will provide details of animal models and research methods to investigate ONJ. The aim is to educate and inform clinicians and researchers on the available knowledge base on ONJ Education objectives. Understand bone remodeling in the jaws as compared to appendicular sites Understand animal models for studying ONJ Understand unique features of the craniofacial region that may predispose them to ONJ. This program is supported financially by The Ohio State University College of Dentistry.


	9:45 AM	Introductory Remarks S.S. HUJA, Ohio State University, Columbus, USA
0103	9:50 AM	Osteonecrosis: Why the Jaw? L. MCCAULEY, University of Michigan, Ann Arbor, USA
	10:10 AM	Animal Models for Studying ONJ M. ALLEN, Indiana University, Indianapolis, USA
	10:30 AM	Animal models to study bone remodeling in jaws S.S. HUJA, Ohio State University, Columbus, USA
	10:50 AM	Clinical Aspects of ONJ to Developing Animal Models S. KOKA, Mayo School of Graduate Medical Education, Rochester, MN, USA
	11:10 AM	Discussion

Back to the: Symposium Program